Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 698


Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis.

Liu N, Chen NY, Cui RX, Li WF, Li Y, Wei RR, Zhang MY, Sun Y, Huang BJ, Chen M, He QM, Jiang N, Chen L, Cho WC, Yun JP, Zeng J, Liu LZ, Li L, Guo Y, Wang HY, Ma J.

Lancet Oncol. 2012 Jun;13(6):633-41. doi: 10.1016/S1470-2045(12)70102-X. Epub 2012 May 3.


Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis.

Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, Hu M, Chen GZ, Liao B, Lu J, Zhao HW, Chen W, He YL, Wang HY, Xie D, Luo JH.

Lancet Oncol. 2013 Dec;14(13):1295-306. doi: 10.1016/S1470-2045(13)70491-1. Epub 2013 Nov 13. Erratum in: Lancet Oncol. 2014 Jan;15(1):e4.


A four-miRNA signature identified from genome-wide serum miRNA profiling predicts survival in patients with nasopharyngeal carcinoma.

Liu N, Cui RX, Sun Y, Guo R, Mao YP, Tang LL, Jiang W, Liu X, Cheng YK, He QM, Cho WC, Liu LZ, Li L, Ma J.

Int J Cancer. 2014 Mar 15;134(6):1359-68. doi: 10.1002/ijc.28468. Epub 2013 Sep 30.


Profiling plasma microRNA in nasopharyngeal carcinoma with deep sequencing.

Wang HY, Yan LX, Shao Q, Fu S, Zhang ZC, Ye W, Zeng YX, Shao JY.

Clin Chem. 2014 May;60(5):773-82. doi: 10.1373/clinchem.2013.214213. Epub 2014 Feb 21.


Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections.

Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Fuso Nerini I, Mangioni C, Cattoretti G, Clivio L, Beltrame L, Katsaros D, Scarampi L, Menato G, Perego P, Chiorino G, Buda A, Romualdi C, D'Incalci M.

Lancet Oncol. 2011 Mar;12(3):273-85. doi: 10.1016/S1470-2045(11)70012-2. Epub 2011 Feb 21.


Clinical significance and prognostic value of microRNA expression signatures in hepatocellular carcinoma.

Wei R, Huang GL, Zhang MY, Li BK, Zhang HZ, Shi M, Chen XQ, Huang L, Zhou QM, Jia WH, Zheng XF, Yuan YF, Wang HY.

Clin Cancer Res. 2013 Sep 1;19(17):4780-91. doi: 10.1158/1078-0432.CCR-12-2728. Epub 2013 Jun 28.


Cell-free microRNA expression profiles in malignant effusion associated with patient survival in non-small cell lung cancer.

Wang T, Lv M, Shen S, Zhou S, Wang P, Chen Y, Liu B, Yu L, Hou Y.

PLoS One. 2012;7(8):e43268. doi: 10.1371/journal.pone.0043268. Epub 2012 Aug 24.


Identification of recurrence-related microRNAs in hepatocellular carcinoma following liver transplantation.

Han ZB, Zhong L, Teng MJ, Fan JW, Tang HM, Wu JY, Chen HY, Wang ZW, Qiu GQ, Peng ZH.

Mol Oncol. 2012 Aug;6(4):445-57. doi: 10.1016/j.molonc.2012.04.001. Epub 2012 Apr 17.


Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature.

Tutt A, Wang A, Rowland C, Gillett C, Lau K, Chew K, Dai H, Kwok S, Ryder K, Shu H, Springall R, Cane P, McCallie B, Kam-Morgan L, Anderson S, Buerger H, Gray J, Bennington J, Esserman L, Hastie T, Broder S, Sninsky J, Brandt B, Waldman F.

BMC Cancer. 2008 Nov 21;8:339. doi: 10.1186/1471-2407-8-339.


Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.

Chang W, Gao X, Han Y, Du Y, Liu Q, Wang L, Tan X, Zhang Q, Liu Y, Zhu Y, Yu Y, Fan X, Zhang H, Zhou W, Wang J, Fu C, Cao G.

Gut. 2014 Sep;63(9):1457-67. doi: 10.1136/gutjnl-2013-305475. Epub 2013 Oct 30.


Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling.

Lim HY, Sohn I, Deng S, Lee J, Jung SH, Mao M, Xu J, Wang K, Shi S, Joh JW, Choi YL, Park CK.

Ann Surg Oncol. 2013 Nov;20(12):3747-53. doi: 10.1245/s10434-013-3070-y. Epub 2013 Jun 26.


Reduced expression of Dicer11 is associated with poor prognosis in patients with nasopharyngeal carcinoma.

Liu N, Cui RX, He QM, Huang BJ, Sun Y, Xie D, Zeng J, Wang HY, Ma J.

Med Oncol. 2013 Mar;30(1):360. doi: 10.1007/s12032-012-0360-3. Epub 2013 Jan 10.


Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial.

Chen L, Hu CS, Chen XZ, Hu GQ, Cheng ZB, Sun Y, Li WX, Chen YY, Xie FY, Liang SB, Chen Y, Xu TT, Li B, Long GX, Wang SY, Zheng BM, Guo Y, Sun Y, Mao YP, Tang LL, Chen YM, Liu MZ, Ma J.

Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7.


Methods and matrices: approaches to identifying miRNAs for nasopharyngeal carcinoma.

Plieskatt JL, Rinaldi G, Feng Y, Levine PH, Easley S, Martinez E, Hashmi S, Sadeghi N, Brindley PJ, Bethony JM, Mulvenna JP.

J Transl Med. 2014 Jan 6;12:3. doi: 10.1186/1479-5876-12-3.


High-throughput microRNA (miRNAs) arrays unravel the prognostic role of MiR-211 in pancreatic cancer.

Giovannetti E, van der Velde A, Funel N, Vasile E, Perrone V, Leon LG, De Lio N, Avan A, Caponi S, Pollina LE, Gallá V, Sudo H, Falcone A, Campani D, Boggi U, Peters GJ.

PLoS One. 2012;7(11):e49145. doi: 10.1371/journal.pone.0049145. Epub 2012 Nov 14.


Secreted protein acidic and rich in cysteine (SPARC) is associated with nasopharyngeal carcinoma metastasis and poor prognosis.

Wang HY, Li YY, Shao Q, Hou JH, Wang F, Cai MB, Zeng YX, Shao JY.

J Transl Med. 2012 Feb 9;10:27. doi: 10.1186/1479-5876-10-27.


Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.

Ahmed FE, Ahmed NC, Vos PW, Bonnerup C, Atkins JN, Casey M, Nuovo GJ, Naziri W, Wiley JE, Mota H, Allison RR.

Cancer Genomics Proteomics. 2013 May-Jun;10(3):93-113.


Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.

Liang SB, Deng YM, Zhang N, Lu RL, Zhao H, Chen HY, Li SE, Liu DS, Chen Y.

BMC Cancer. 2013 May 27;13:260. doi: 10.1186/1471-2407-13-260.


miRNA expression in diffuse large B-cell lymphoma treated with chemoimmunotherapy.

Montes-Moreno S, Martinez N, Sanchez-Espiridión B, Díaz Uriarte R, Rodriguez ME, Saez A, Montalbán C, Gomez G, Pisano DG, García JF, Conde E, Gonzalez-Barca E, Lopez A, Mollejo M, Grande C, Martinez MA, Dunphy C, Hsi ED, Rocque GB, Chang J, Go RS, Visco C, Xu-Monette Z, Young KH, Piris MA.

Blood. 2011 Jul 28;118(4):1034-40. doi: 10.1182/blood-2010-11-321554. Epub 2011 Jun 1.


Tumor volume is an independent prognostic indicator of local control in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.

Feng M, Wang W, Fan Z, Fu B, Li J, Zhang S, Lang J.

Radiat Oncol. 2013 Sep 5;8:208. doi: 10.1186/1748-717X-8-208.

Supplemental Content

Support Center